{
    "title": "Melbourne-made COVID-19 jabs undergo trial",
    "url": "https://www.dailymail.co.uk/wires/aap/article-10649873/Melbourne-COVID-19-jabs-undergo-trial.html",
    "date": "2022-03-24",
    "keywords": [
        "covid19",
        "rbd",
        "institute",
        "immunity",
        "virus",
        "protein",
        "doherty",
        "dose",
        "vaccine",
        "infection",
        "omicron",
        "variant",
        "need",
        "melbourne",
        "vaccination",
        "world",
        "trial",
        "melbournemade",
        "mrna",
        "jabs",
        "science",
        "response",
        "tip",
        "sarscov2",
        "spike",
        "receptor",
        "body",
        "cent",
        "neutralising",
        "antibody",
        "beta",
        "mice",
        "strain",
        "inlab",
        "activity",
        "delta",
        "researcher",
        "georgia",
        "deliyannis",
        "mouse",
        "jab",
        "director",
        "sharon",
        "lewin",
        "emergence",
        "generation",
        "addition",
        "australia",
        "ability",
        "supply",
        "safety",
        "efficacy",
        "study",
        "theyve",
        "victoria",
        "thursday",
        "week",
        "march",
        "health",
        "department",
        "hospital",
        "icu",
        "ventilator"
    ],
    "category": [
        "wires",
        "aap"
    ]
}